Open AccessPrevention of Renal Impairment by Continuous Infusion of Human Atrial Natriuretic Peptide after Liver Transplantation
Author(s) -
Nobuhisa Akamatsu,
Yasuhiko Sugawara,
Sumihito Tamura,
Junichi Kaneko,
Junichi Togashi,
Yoji Kishi,
Hiroshi Imamura,
Norihiro Kokudo,
Masatoshi Makuuchi
Publication year - 2005
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000178354.60959.2d
Subject(s) - medicine , hemodialysis , atrial natriuretic peptide , transplantation , furosemide , liver transplantation , natriuretic peptide , hemodynamics , renal function , cardiology , liver disease , urology , gastroenterology , heart failure
Acute renal failure occurring immediately after liver transplantation and requiring hemodialysis is a major problem resulting in a poor prognosis. We investigated the efficacy of human atrial natriuretic peptide, which has potent natriuretic effects and unique protective effects for glomeruli in preventing acute renal failure after liver transplantation.